Dataconomy
  • News
    • Artificial Intelligence
    • Cybersecurity
    • DeFi & Blockchain
    • Finance
    • Gaming
    • Startups
    • Tech
  • Industry
  • Research
  • Resources
    • Articles
    • Guides
    • Case Studies
    • Glossary
    • Whitepapers
  • Newsletter
  • + More
    • Conversations
    • Events
    • About
      • About
      • Contact
      • Imprint
      • Legal & Privacy
      • Partner With Us
Subscribe
No Result
View All Result
  • AI
  • Tech
  • Cybersecurity
  • Finance
  • DeFi & Blockchain
  • Startups
  • Gaming
Dataconomy
  • News
    • Artificial Intelligence
    • Cybersecurity
    • DeFi & Blockchain
    • Finance
    • Gaming
    • Startups
    • Tech
  • Industry
  • Research
  • Resources
    • Articles
    • Guides
    • Case Studies
    • Glossary
    • Whitepapers
  • Newsletter
  • + More
    • Conversations
    • Events
    • About
      • About
      • Contact
      • Imprint
      • Legal & Privacy
      • Partner With Us
Subscribe
No Result
View All Result
Dataconomy
No Result
View All Result

A new robot will endure labor so that humans no longer have to

Initial reactions to the announcement were mixed, encompassing both enthusiasm and apprehension.

byEmre Çıtak
August 26, 2025
in Artificial Intelligence, News
Home News Artificial Intelligence
Share on FacebookShare on TwitterShare on LinkedInShare on WhatsAppShare on e-mail

Kaiwa Technology, a Chinese technology firm, is developing a humanoid robot named GEAIR with the capacity to gestate and deliver a human infant using a synthetic uterus, artificial amniotic fluid, and a plastic umbilical cord. The device is intended to facilitate the complete gestation of a fetus, from embryo implantation to full-term delivery, without the involvement of a biological human body.

Dr. Zhang Qifeng, Chief Executive Officer of Kaiwa Technology, indicated to Kuai Ke Zhi, as reported by Chosun Biz, that the GEAIR prototype is in an advanced stage of development. The company anticipates a market launch within the next year, projecting a retail price of approximately 100,000 yuan, which equates to $14,000 in United States currency. The intended function of GEAIR is to supplant human pregnancy, not to augment or assist it. This objective sparked debate and diverse reactions across social media platforms.

Initial reactions to the announcement were mixed, encompassing both enthusiasm and apprehension. As one commenter noted, “Women have finally been liberated.” Another individual suggested a willingness to purchase the device contingent upon its affordability relative to their annual income, stating, “If the price is only half my annual salary, I’d buy it immediately.”

Stay Ahead of the Curve!

Don't miss out on the latest insights, trends, and analysis in the world of data, technology, and startups. Subscribe to our newsletter and get exclusive content delivered straight to your inbox.

The news rapidly gained traction on Chinese social media platforms, generating considerable discussion. Some commentators voiced concerns regarding the ethical implications, characterizing the technology as potentially cruel or unnatural. Contrarily, other individuals viewed it as a progressive advancement. Videos showcasing the robot garnered thousands of comments within a short timeframe on Douyin, the Chinese equivalent of TikTok, demonstrating the high level of public interest and engagement.

Specific details regarding the fertilization process remain undisclosed. Zhang did not address the methodologies for managing maternal hormone levels within the artificial environment. The potential consequences of fetal development within a plastic enclosure on the infant’s neurological development were also not clarified. However, Dr. Zhang suggested that these considerations would be addressed subsequently.

Artificial wombs have been previously explored in scientific research. In 2017, scientists successfully sustained premature lambs in a sealed environment filled with synthetic amniotic fluid, allowing them to develop to a viable stage. These lambs exhibited normal physiological development, including the growth of wool. The current endeavor, however, focuses on replicating human gestation within a completely artificial system. Rising infertility rates in China are driving the expansion of government-supported In Vitro Fertilization (IVF) programs, underscoring the practical demand for alternative reproductive technologies. The broader societal ramifications of artificially creating human life are under consideration.


Featured image credit

Tags: AIFeaturedrobot

Related Posts

Your YouTube Music 2025 Recap is rolling out now with a Gemini twist

Your YouTube Music 2025 Recap is rolling out now with a Gemini twist

November 25, 2025
Altman and Ive target 2027 for screenless AI device launch

Altman and Ive target 2027 for screenless AI device launch

November 25, 2025
Job listing reveals ‘Aluminium’ codename for Android desktop OS

Job listing reveals ‘Aluminium’ codename for Android desktop OS

November 25, 2025
Gmail Android notifications now show image attachment previews

Gmail Android notifications now show image attachment previews

November 25, 2025
Xbox Crocs arrive November 25 for

Xbox Crocs arrive November 25 for $80

November 25, 2025
SEC grants regulatory safety to Solana DePIN project Fuse

SEC grants regulatory safety to Solana DePIN project Fuse

November 25, 2025

LATEST NEWS

Your YouTube Music 2025 Recap is rolling out now with a Gemini twist

Altman and Ive target 2027 for screenless AI device launch

Job listing reveals ‘Aluminium’ codename for Android desktop OS

Gmail Android notifications now show image attachment previews

Xbox Crocs arrive November 25 for $80

SEC grants regulatory safety to Solana DePIN project Fuse

Dataconomy

COPYRIGHT © DATACONOMY MEDIA GMBH, ALL RIGHTS RESERVED.

  • About
  • Imprint
  • Contact
  • Legal & Privacy

Follow Us

  • News
    • Artificial Intelligence
    • Cybersecurity
    • DeFi & Blockchain
    • Finance
    • Gaming
    • Startups
    • Tech
  • Industry
  • Research
  • Resources
    • Articles
    • Guides
    • Case Studies
    • Glossary
    • Whitepapers
  • Newsletter
  • + More
    • Conversations
    • Events
    • About
      • About
      • Contact
      • Imprint
      • Legal & Privacy
      • Partner With Us
No Result
View All Result
Subscribe

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy Policy.